These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11335892)

  • 1. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
    Mangano A; Gonzalez E; Dhanda R; Catano G; Bamshad M; Bock A; Duggirala R; Williams K; Mummidi S; Clark RA; Ahuja SS; Dolan MJ; Bologna R; Sen L; Ahuja SK
    J Infect Dis; 2001 Jun; 183(11):1574-85. PubMed ID: 11335892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of natural chemokine receptor polymorphisms on perinatal transmission of human immunodeficiency virus type 1.
    Kostrikis LG
    Teratology; 2000 May; 61(5):387-90. PubMed ID: 10777836
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
    Dolan MJ; Kulkarni H; Camargo JF; He W; Smith A; Anaya JM; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RA; Anderson SA; Delmar J; O'Connell RJ; Lloyd A; Martin J; Ahuja SS; Agan BK; Walker BD; Deeks SG; Ahuja SK
    Nat Immunol; 2007 Dec; 8(12):1324-36. PubMed ID: 17952079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression.
    Mangano A; Rocco C; Marino SM; Mecikovsky D; Genre F; Aulicino P; Bologna R; Sen L
    J Infect Dis; 2008 Sep; 198(5):694-700. PubMed ID: 18637753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child.
    Casper CH; Clevestig P; Carlenor E; Leitner T; Anzén B; Lidman K; Belfrage E; Albert J; Bohlin AB; Navér L; Lindgren S; Fenyö EM; Ehrnst AC
    J Infect Dis; 2002 Oct; 186(7):914-21. PubMed ID: 12232831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
    Iversen AK; Christiansen CB; Attermann J; Eugen-Olsen J; Schulman S; Berntorp E; Ingerslev J; Fugger L; Scheibel E; Tengborn L; Gerstoft J; Dickmeiss E; Svejgaard A; Skinhøj P
    J Infect Dis; 2003 Jan; 187(2):215-25. PubMed ID: 12552446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.
    Gervaix A; Nicolas J; Portales P; Posfay-Barbe K; Wyler CA; Segondy M; Avinens O; Siegrist CA; Clot J; Eliaou JF; Astruc J; Corbeau P
    J Infect Dis; 2002 Apr; 185(8):1055-61. PubMed ID: 11930315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
    Scarlatti G
    AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission.
    Mangano A; Prada F; Roldán A; Picchio G; Bologna R; Sen L
    AIDS; 1998 Jan; 12(1):109-10. PubMed ID: 9456261
    [No Abstract]   [Full Text] [Related]  

  • 17. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
    Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM
    J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.
    Villalba N; Pérez-Olmeda M; de José M; Hernández M; Sirera R; Español T; González-Molina A; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 May; 18(5):389-91. PubMed ID: 10421054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.